Ovarian cancer echocardiography or ultrasound: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 17: Line 17:
*The specificity of ultrasound in detecting malignant masses is low but the sensitivity is high because some may turn out to be malignant after surgical evaluation(a reasonable chance of being malignant)
*The specificity of ultrasound in detecting malignant masses is low but the sensitivity is high because some may turn out to be malignant after surgical evaluation(a reasonable chance of being malignant)
*Benign adnexal mass findings:
*Benign adnexal mass findings:
** Unilocular cyst
** No solid components and if present, <7 mm in diameter
** Detection of acoustic shadowing
** Multilocular cyst <10 cm in diameter
** No blood flow
*Malignant adnexal mass finding:
*Malignant adnexal mass finding:
** Solid component : not hyperechoic, nodular or papillary,
** Solid component : not hyperechoic, nodular or papillary,

Revision as of 20:07, 10 July 2019


Ovarian cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classifications

Pathophysiology

Causes of Ovarian cancer

Differentiating Ovarian cancer from other Diseases

Epidemiology & Demographics

Risk Factors

Screening

Natural History, Complications & Prognosis

Diagnosis

History & Symptoms

Physical Examination

Staging

Laboratory Findings

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Ovarian cancer echocardiography or ultrasound On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Ovarian cancer echocardiography or ultrasound

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Ovarian cancer echocardiography or ultrasound

CDC on Ovarian cancer echocardiography or ultrasound

Ovarian cancer echocardiography or ultrasound in the news

Blogs on Ovarian cancer echocardiography or ultrasound

Directions to Hospitals Treating Ovarian cancer

Risk calculators and risk factors for Ovarian cancer echocardiography or ultrasound

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Ovarian cancer can be detected incidentally

  • Pelvic ultrasound is the first imaging study that should be done to evaluate adnexal mass (ovary, fallopian tube, surrounding connective tissue)[1]
  • The sensitivity and specificity of pelvic ultrasound are 86-91% and 68-83% respectively[2]
  • The adnexal mass can present as one of the following
    • Pain and pressure
    • During physical exam
    • Incidentally on pelvic ultrasound
  • Ultrasonography helps approaching if the mass could be benign or if it has certain characteristics that increases the probability of being malignant
  • The specificity of ultrasound in detecting benign masses is high (almost certainly benign)
  • The specificity of ultrasound in detecting malignant masses is low but the sensitivity is high because some may turn out to be malignant after surgical evaluation(a reasonable chance of being malignant)
  • Benign adnexal mass findings:
    • Unilocular cyst
    • No solid components and if present, <7 mm in diameter
    • Detection of acoustic shadowing
    • Multilocular cyst <10 cm in diameter
    • No blood flow
  • Malignant adnexal mass finding:
    • Solid component : not hyperechoic, nodular or papillary,
    • Irregularly thick septations , >2 to 3 mm.
    • Detection of flow in the solid component by the color power doppler
    • Detection of peritoneal fluid (ascites)
    • Detection of peritoneal masses, lymphadenopathy, or matted bowel


References

  1. van Nagell JR, Miller RW (2016). "Evaluation and Management of Ultrasonographically Detected Ovarian Tumors in Asymptomatic Women". Obstet Gynecol. 127 (5): 848–58. doi:10.1097/AOG.0000000000001384. PMID 27054927.
  2. Myers ER, Bastian LA, Havrilesky LJ, Kulasingam SL, Terplan MS, Cline KE; et al. (2006). "Management of adnexal mass". Evid Rep Technol Assess (Full Rep) (130): 1–145. PMC 4781260. PMID 17854238.

Template:WH

Template:WS